Response by Methawasin and Granzier to Letter Regarding Article, "Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction"
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Li E, Xi W, Han Y, Brozovich F
. Phosphodiesterase expression in the normal and failing heart. Arch Biochem Biophys. 2018; 662:160-168.
DOI: 10.1016/j.abb.2018.12.013.
View
2.
Eschenhagen T
. Beta-adrenergic signaling in heart failure-adapt or die. Nat Med. 2008; 14(5):485-7.
DOI: 10.1038/nm0508-485.
View
3.
Hidalgo C, Granzier H
. Tuning the molecular giant titin through phosphorylation: role in health and disease. Trends Cardiovasc Med. 2013; 23(5):165-71.
PMC: 3622841.
DOI: 10.1016/j.tcm.2012.10.005.
View
4.
Karam S, Margaria J, Bourcier A, Mika D, Varin A, Bedioune I
. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure. Circulation. 2020; 142(2):161-174.
DOI: 10.1161/CIRCULATIONAHA.119.042573.
View
5.
Methawasin M, Strom J, Borkowski T, Hourani Z, Runyan R, Smith 3rd J
. Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction. Circ Heart Fail. 2020; 13(5):e006609.
PMC: 7895451.
DOI: 10.1161/CIRCHEARTFAILURE.119.006609.
View